Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography

Physics in Medicine and Biology

Volumn 58, Issue 2, 2013, Pages 187-203

  Willaime, J M Y ^a   Turkheimer, F E ^b   Kenny, L M ^a   Aboagye, E O ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CLINICAL RESPONSE; CLINICAL TRIAL; CORRELATION COEFFICIENT; DESCRIPTORS; EMISSION TOMOGRAPHY; IMAGE DESCRIPTORS; INTENSITY DISTRIBUTION; PROLIFERATING CELLS; TEXTURAL FEATURE; TISSUE TYPES;

CELL PROLIFERATION; CHEMOTHERAPY; DISEASES; PATIENT TREATMENT; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3' FLUOROTHYMIDINE; DIAGNOSTIC AGENT;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; HUMAN; KINETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; TREATMENT FAILURE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CELL PROLIFERATION; DIDEOXYNUCLEOSIDES; HUMANS; KINETICS; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84871574634     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/58/2/187     Document Type: Article

References (34)

1. Amadasun M and King R 1989 Textural features corresponding to textural properties IEEE Trans. Syst. Man Cybern. 19 1264-74 (Pubitemid 20642913)
2. Bass C, Axente M, He J, Sundaresan G, Hirsch J, Hugo G, Zweit J and Pugachev A 2012 Evaluation of the spatial concordance between the intratumoral patterns of 18F-FLT and 18F-FDG uptake in a small animal tumor model 54th AAPM Annual Meeting (Charlotte, USA) Med. Phys. 39 3621
3. Basu S, Kwee T C, Gatenby R, Saboury B, Torigian D A and Alavi A 2011 Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders Eur. J. Nucl. Med. Mol. Imaging 38 987-91
4. Campbell L L and Polyak K 2007 Breast tumor heterogeneity: cancer stem cells or clonal evolution Cell Cycle 6 2332-8 (Pubitemid 350058682)
5. Dasarathy B V and Holder E B 1991 Image characterizations based on joint gray level-run length distributions Pattern Recognit. Lett. 12 497-502
6. Eary J F, O'Sullivan F, O'Sullivan J and Conrad E U 2008 Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome J. Nucl. Med. 49 1973-9
7. El Naqa I et al 2009 Exploring feature-based approaches in PET images for predicting cancer treatment outcomes Pattern Recognit. 42 1162-71
8. Galloway M M 1975 Texture analysis using gray level run lengths Comput. Graph. Image Process. 4 172-9
9. Gerlinger M and Swanton C 2010 How darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine Br. J. Cancer 103 1139-43
10. Gerlinger M et al 2012 Intratumor heterogeneity and branched evolution revealed by multiregion sequencing New Engl. J. Med. 366 883-92
11. Gottesman M M, Fojo T and Bates S E 2002 Multidrug resistance in cancer: role of ATP-dependent transporters Nature Rev. Cancer 2 48-58 (Pubitemid 37328807)
12. Gray K R et al 2010 Kinetic filtering of [(18)F]fluorothymidine in positron emission tomography studies Phys. Med. Biol. 55 695-709
13. Hanahan D and Weinberg R A 2011 Hallmarks of cancer: the next generation Cell 144 646-74
14. Haralick R M, Shanmugam K and Dinstein I H 1973 Textural features for image classification IEEE Trans. Syst. Man Cybern. 3 610-21
15. Kenny L M, Coombes R C, Vigushin D M, Al-Nahhas A, Shousha S and Aboagye E O 2007 Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography Eur. J. Nucl. Med. Mol. Imaging 34 1339-47 (Pubitemid 47312585)
16. Kenny L M, Vigushin D M, Al-Nahhas A, Osman S, Luthra S K, Shousha S, Coombes R C and Aboagye E O 2005 Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F] fluorothymidine-positron emission tomography imaging: evaluation of analytical methods Cancer Res. 65 10104-12 (Pubitemid 41541493)
17. Laking G R, West C, Buckley D L, Matthews J and Price P M 2006 Imaging vascular physiology to monitor cancer treatment Crit. Rev. Oncol. 58 95-113
18. Loh H H, Leu J G and Luo R C 1988 The analysis of natural textures using run length features IEEE Trans. Indust. Electron. 35 323-8
19. Marusyk A and Polyak K 2010 Tumor heterogeneity: causes and consequences Biochim. Biophys. Rev. Cancer 1805 105-17
20. Minchinton A I and Tannock I F 2006 Drug penetration in solid tumours Nature Rev. Cancer 6 583-92 (Pubitemid 44140857)
21. Salskov A, Tammisetti V S, Grierson J and Vesselle H 2007 FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3′-deoxy-3′-[18F]fluorothymidine Semin. Nucl. Med. 37 429-439 (Pubitemid 47498262)
22. Schneider-Kolsky M E, Hart S, Fox J, Midolo P, Stuckey J, Hofman M and Ganju V 2010 The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Breast Cancer Res. 12 R37
23. Segal E et al 2007 Decoding global gene expression programs in liver cancer by noninvasive imaging Nature Biotech. 25 675-80 (Pubitemid 46897204)
24. Soh L K and Tsatsoulis C 1999 Texture analysis of SAR sea ice imagery using gray level co-occurrence matrices IEEE Trans. Geosci. Remote Sens. 37 780-95
25. Therasse P et al 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J. Natl Cancer Inst. 92 205-16
26. Thibault G, Fertil B, Navarro C, Pereira S, Cau P, Levy N, Sequeira J and Mari J-L 2009 Texture indexes and gray level size zone matrix: application to cell nuclei classification Minsk 10th Int. Conf. on Pattern Recognition and Information Processing (Belarus) pp 140-5
27. Tixier F, Hatt M, Le Rest C C, Le Pogam A, Corcos L and Visvikis D 2012 Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET J. Nucl. Med. 53 693-700
28. Tixier F, Le Rest C C, Hatt M, Albarghach N, Pradier O, Metges J P, Corcos L and Visvikis D 2011 Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer J. Nucl. Med. 52 369-78
29. Tomasi G, Turkheimer F and Aboagye E 2012 Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future Mol. Imaging Biol. 14 131-46
30. Turkheimer F, Moresco R M, Lucignani G, Sokoloff L, Fazio F and Schmidt K 1994 The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures J. Cereb. Blood Flow Metab. 14 406-22
31. Turku PET Centre 2011 Decay correction Available at http://www. turkupetcentre.fi/index.php?option=com-content&view=article&id= 192&Itemid=69&lang=en (Accessed 10 July 2011 2011) (Turku, Finland)
32. Vaidya M, Creach K M, Frye J, Dehdashti F, Bradley J D and El Naqa I 2012 Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer Radiother. Oncol. 102 239-45
33. Van Velden F, Cheebsumon P, Yaqub M, Smit E, Hoekstra O, Lammertsma A and Boellaard R 2011 Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies Eur. J. Nucl. Med. Mol. Imaging 38 1636-47
34. Weber W A 2006 Positron emission tomography as an imaging biomarker J. Clin. Oncol. 24 3282-92 (Pubitemid 46622068)